摘要: Objective To study the inheritance and innovation of traditional Chinese medicine, and to offer an insight for the public. Methods Literature review, data retrieval and systematic analysis were used to elaborate and summarize the influence of changes in related classification and policy reform of traditional Chinese medicine (TCM) registration on its inheritance and innovation. The study was carried out in the context of the TCM registration related classification and policy reform and evolution on TCM inheritance and innovation. Results and Conclusion TCM registration plays an important role in the inheritance and innovation of TCM, which greatly influences on its inheritance and innovation. The reform of new registration classification respects the law of TCM research and development, reflecting the establishment of the review and approval system in line with the characteristics of TCM inheritance, which promotes the research and development of new drugs. The establishment of the review and approval system also accelerates the marketing transformation of new traditional Chinese medicine. TCM innovation should attach importance to clinical value orientation and improve the scientific connotation of TCM. Meanwhile, the advantage of China’s accession to ICH, PIC/S and other international drug certification organizations should be taken to speed up the construction of international mutual recognition of TCM standardization system, which can provide a broader path for the inheritance and innovation of TCM in the new era.